Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Stock par value $0.012 per share
-
Shares outstanding
-
41M
-
Number of holders
-
20
-
Total 13F shares, excl. options
-
148K
-
Shares change
-
+6.02K
-
Total reported value, excl. options
-
$909K
-
Value change
-
+$37.7K
-
Number of buys
-
4
-
Number of sells
-
-9
-
Price
-
$6.11
Significant Holders of ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) as of Q1 2017
25 filings reported holding ORMP - ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share as of Q1 2017.
ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 148K shares
of 41M outstanding shares and own 0.36% of the company stock.
Largest 10 shareholders include GLENMEDE TRUST CO NA (30K shares), BARCLAYS PLC (29.9K shares), PNC Financial Services Group, Inc. (21.2K shares), Acrospire Investment Management LLC (14.6K shares), WELLS FARGO & COMPANY/MN (14.1K shares), MORGAN STANLEY (13K shares), Cutler Group LP (6.1K shares), Penserra Capital Management LLC (4.1K shares), Sterling Investment Advisors, Ltd. (3.15K shares), and Creative Planning (2K shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.